CRM - Salesforce Gains Momentum With GenAI Platform Here's What 9 Analysts Have To Say | Benzinga
Shares of Salesforce Inc (NYSE: CRM) rose in premarket trading on Thursday, after the company reported higher-than-expected sales and earnings for the fourth quarter.
Here are some key analyst takeaways from the release.
- JMP Securities analyst Patrick Walravens maintained a Market Perform rating, while raising the price target from $293 to $342.
- Truist Securities analyst Terry Tillman reiterated a Buy rating, while lifting the price target from $275 to $360.
- Mizuho Securities analyst Gregg Moskowitz reaffirmed a Buy rating, while raising the price target from $325 to $345.
- BMO Capital Markets analyst Keith Bachman maintained an Outperform rating, while lifting the price target from $325 to $335.
- Piper Sandler analyst Brent Bracelin reiterated a Neutral rating, while raising the price target from $285 to $300.
- RBC Capital Markets analyst Rishi Jaluria reaffirmed an Outperform rating, while lifting the price target from $285 to $325.
- Roth Capital Partners analyst Richard Baldry maintained a Buy rating, while raising the price target to $335.
- Oppenheimer analyst Brian Schwartz reiterated an Outperform rating and price target of $325.
- Wedbush analyst Daniel Ives reaffirmed an Outperform rating and price target of $325.
Check out other analyst stock ratings.
JMP Securities: Salesforce's fourth-quarter non-GAAP earnings of $2.29 per share beat the consensus of $2.27 per share, while non-GAAP operating margin of 31.4% came in slightly short versus expectations of 31.5%, he added.
Management guiding first-quarter revenue of $9.12 billion to $9.17 billion, which includes a currency headwind of $50 million, and full-year revenue of $37.70 billion to $38.00 billion, which includes a $100 million forex headwind, the analyst stated.
Truist: Salesforce reported "solid” quarterly results, "with upside to our ests for rev, ...